2
Indication details
- Control Arm
- Single arm
- Tumour Type
-
Gynaecological Malignancies
- Tumour Sub-type
- Epithelial ovarian, fallopian tube or primary peritoneal cancer
- Tumour Stage
- Advanced
- Tumour Sub-Group
- FRα positive
- Trial Name
- SORAYA
- NCT Number
- NCT04296890
- Trial Phase
- Phase II
Approval details
- FDA Approval
- FDA approval March 2024
- EMA Approval
- EMA approved Sept 2024
Primary Outcome(s)
- Primary Outcome(s)
- ORR DOR
- Evaluated Outcome
- ORR DOR
- Form(s)
- Form 3
Outcome Data
- PFS Control
- 4.3 months
- ORR
- 32.4%
- DoR
- 6.9 months
Adjustments
- QoL Comment
-
Not qualified for an ESMO-MCBS credit
Score (after adjustments)
- Preliminary non-curative score
-
2
- Non-curative score
-
2
Scorecard details
- ESMO-MCBS version
- ESMO-MCBS v1.1
- Scorecard ID
- 376
- Scorecard version
- 1
- Issue date
- 21.04.2023
- Last update
- 21.11.2024